Spots Global Cancer Trial Database for Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
Official Title: Conformal and Intensity Modulated Irradiation for Oropharyngeal Cancer
Study ID: NCT00006360
Study Description
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III oropharyngeal cancer.
Detailed Description: OBJECTIVES: * Assess target coverage and major salivary gland sparing in patients with stage II or III oropharyngeal cancer treated with intensity-modulated radiotherapy. * Determine the nature and prevalence of acute and late side effects of this treatment in these patients. * Determine the rate and pattern of locoregional tumor recurrence in these patients after this treatment. OUTLINE: This is a multicenter study. Patients receive 3-D conformal radiotherapy and/or intensity-modulated radiotherapy daily 5 days a week for 6 weeks, in an effort to spare major salivary glands. Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter. PROJECTED ACCRUAL: Approximately 57-64 patients will be accrued for this study over 27 months.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Foundation for Cancer Research and Education, Phoenix, Arizona, United States
UCSF Comprehensive Cancer Center, San Francisco, California, United States
University of Florida Shands Cancer Center, Gainesville, Florida, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
CCOP - Kansas City, Kansas City, Missouri, United States
Monmouth Medical Center, Long Branch, New Jersey, United States
Community Regional Cancer Center at Community Medical Center, Toms River, New Jersey, United States
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
Dixie Regional Medical Center, Saint George, Utah, United States
LDS Hospital, Salt Lake City, Utah, United States
Community Cancer Center at Rutland Regional Medical Center, Rutland, Vermont, United States
CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States
Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States
All Saints Cancer Center at All Saints Healthcare, Racine, Wisconsin, United States
Stollery Children's Hospital at University of Alberta Hospital, Edmonton, Alberta, Canada
Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
McGill Cancer Centre at McGill University, Montreal, Quebec, Canada
Contact Details
Name: Avraham Eisbruch, MD
Affiliation: University of Michigan Rogel Cancer Center
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
